536 related articles for article (PubMed ID: 16389186)
1. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
Sugarbaker PH
Lancet Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16389186
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
3. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
4. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
[TBL] [Abstract][Full Text] [Related]
5. Commentary on 'Survival of patients with pseudomyxoma peritonei treated by serial debulking'.
Moran BJ
Colorectal Dis; 2010 Sep; 12(9):872-3. PubMed ID: 20718839
[No Abstract] [Full Text] [Related]
6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
[TBL] [Abstract][Full Text] [Related]
7. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Hosch WP; Rudi J; Stremmel W
Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
[TBL] [Abstract][Full Text] [Related]
8. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
Murphy EM; Sexton R; Moran BJ
Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
[TBL] [Abstract][Full Text] [Related]
9. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal administration of a combined CDDP, 5-FU and MMC therapy for pseudomyxoma peritonei].
Sasaki A; Terashima M; Okamoto K; Ikeda K; Takagane A; Takiyama I; Shimada Y; Yamamoto M; Nakajima J; Sasaki N; Saito K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1828-31. PubMed ID: 10560405
[TBL] [Abstract][Full Text] [Related]
11. [Peritoneal tumor pathology - case no. 1: pseudomyxoma peritonei].
Dartigues P
Ann Pathol; 2015 Aug; 35(4):311-20. PubMed ID: 26210688
[No Abstract] [Full Text] [Related]
12. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.
Dayal S; Taflampas P; Riss S; Chandrakumaran K; Cecil TD; Mohamed F; Moran BJ
Dis Colon Rectum; 2013 Dec; 56(12):1366-72. PubMed ID: 24201390
[TBL] [Abstract][Full Text] [Related]
13. Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
Sugarbaker PH
Br J Surg; 2002 Feb; 89(2):208-12. PubMed ID: 11856136
[TBL] [Abstract][Full Text] [Related]
14. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
Sugarbaker PH
J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
[No Abstract] [Full Text] [Related]
15. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
[TBL] [Abstract][Full Text] [Related]
16. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
[TBL] [Abstract][Full Text] [Related]
17. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
Chua TC; Al-Zahrani A; Saxena A; Liauw W; Zhao J; Morris DL
J Am Coll Surg; 2010 Oct; 211(4):526-35. PubMed ID: 20729102
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.
Zoetmulder FA; Sugarbaker PH
Eur J Cancer; 1996 Sep; 32A(10):1727-33. PubMed ID: 8983281
[TBL] [Abstract][Full Text] [Related]
19. Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Iavazzo C; Spiliotis J
Updates Surg; 2020 Sep; 72(3):923-924. PubMed ID: 32602012
[No Abstract] [Full Text] [Related]
20. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.
Elias D; Gilly F; Quenet F; Bereder JM; Sidéris L; Mansvelt B; Lorimier G; Glehen O;
Eur J Surg Oncol; 2010 May; 36(5):456-62. PubMed ID: 20227231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]